| Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22–CCR4 axis A Maolake, K Izumi, K Shigehara, A Natsagdorj, H Iwamoto, S Kadomoto, ... Oncotarget 8 (6), 9739, 2017 | 125 | 2017 |
| Tumor necrosis factor‐α induces prostate cancer cell migration in lymphatic metastasis through CCR 7 upregulation A Maolake, K Izumi, A Natsagdorj, H Iwamoto, S Kadomoto, T Makino, ... Cancer science 109 (5), 1524-1531, 2018 | 93 | 2018 |
| Use of preoperative factors including urodynamic evaluations and nerve‐sparing status for predicting urinary continence recovery after robot‐assisted radical prostatectomy … Y Kadono, S Ueno, S Kadomoto, H Iwamoto, Y Takezawa, K Nakashima, ... Neurourology and Urodynamics 35 (8), 1034-1039, 2016 | 67 | 2016 |
| CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells A Natsagdorj, K Izumi, K Hiratsuka, K Machioka, H Iwamoto, R Naito, ... Cancer science 110 (1), 279-288, 2019 | 46 | 2019 |
| Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer K Izumi, A Mizokami, HP Lin, HM Ho, H Iwamoto, A Maolake, ... Oncotarget 7 (7), 8389, 2016 | 45 | 2016 |
| Tumor-associated macrophages induce migration of renal cell carcinoma cells via activation of the CCL20-CCR6 axis S Kadomoto, K Izumi, K Hiratsuka, T Nakano, R Naito, T Makino, ... Cancers 12 (1), 89, 2019 | 42 | 2019 |
| Coffee diterpenes kahweol acetate and cafestol synergistically inhibit the proliferation and migration of prostate cancer cells H Iwamoto, K Izumi, A Natsagdorj, R Naito, T Makino, S Kadomoto, ... The Prostate 79 (5), 468-479, 2019 | 39 | 2019 |
| Is the CC motif ligand 2–CC chemokine receptor 2 axis a promising target for cancer therapy and diagnosis? H Iwamoto, K Izumi, A Mizokami International Journal of Molecular Sciences 21 (23), 9328, 2020 | 36 | 2020 |
| C‐C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment S Urata, K Izumi, K Hiratsuka, A Maolake, A Natsagdorj, K Shigehara, ... Cancer science 109 (3), 724-731, 2018 | 34 | 2018 |
| Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines K Machioka, K Izumi, Y Kadono, H Iwamoto, R Naito, T Makino, ... Oncotarget 9 (22), 16185, 2018 | 31 | 2018 |
| Intraoperative hypotension caused by oral administration of 5‐aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer T Nohara, Y Kato, T Nakano, T Nakagawa, H Iwamoto, H Yaegashi, ... International Journal of Urology 26 (11), 1064-1068, 2019 | 29 | 2019 |
| Prognosis of patients with prostate cancer and middle range prostate-specific antigen levels of 20–100 ng/mL H Iwamoto, K Izumi, Y Kadono, A Mizokami International braz j urol 45, 61-67, 2019 | 24 | 2019 |
| Androgen receptor signaling‐targeted therapy and taxane chemotherapy induce visceral metastasis in castration‐resistant prostate cancer H Iwamoto, K Izumi, T Shimada, H Kano, S Kadomoto, T Makino, R Naito, ... The Prostate 81 (1), 72-80, 2021 | 20 | 2021 |
| Anti-proliferative and anti-migratory properties of coffee diterpenes kahweol acetate and cafestol in human renal cancer cells T Makino, K Izumi, K Hiratsuka, H Kano, T Shimada, T Nakano, ... Scientific Reports 11 (1), 675, 2021 | 18 | 2021 |
| Metastasectomy improves survival in patients with metastatic urothelial carcinoma H Iwamoto, K Izumi, Y Shimura, A Natsagdorj, A Maolake, Y Takezawa, ... Anticancer Research 36 (10), 5557-5561, 2016 | 15 | 2016 |
| Three-dimensional morphological analysis of spermatogenesis in aged mouse testes T Nakano, H Nakata, S Kadomoto, H Iwamoto, H Yaegashi, M Iijima, ... Scientific Reports 11 (1), 23007, 2021 | 11 | 2021 |
| Sarcopenia and visceral metastasis at cabazitaxel initiation predict prognosis in patients with castration-resistant prostate cancer receiving cabazitaxel chemotherapy H Iwamoto, H Kano, T Shimada, R Naito, T Makino, S Kadomoto, ... in vivo 35 (3), 1703-1709, 2021 | 11 | 2021 |
| A novel risk classification score for malignant ureteral obstruction: a multicenter prospective validation study K Izumi, T Shima, K Shigehara, K Sawada, R Naito, Y Kato, M Ofude, ... Scientific Reports 11 (1), 4455, 2021 | 11 | 2021 |
| Gemcitabine plus cisplatin split versus gemcitabine plus carboplatin for advanced urothelial cancer with cisplatin-unfit renal function K Izumi, H Iwamoto, H Yaegashi, K Shigehara, T Nohara, Y Kadono, ... in vivo 33 (1), 167-172, 2019 | 11 | 2019 |
| Treatment outcomes in neuroendocrine prostate cancer H Iwamoto, R Nakagawa, T Makino, S Kadomoto, H Yaegashi, T Nohara, ... Anticancer Research 42 (4), 2167-2176, 2022 | 10 | 2022 |
